| 1 | other | 90,133 |
| 2 | miscellaneous | 182 |
| 3 | non-pain | 12 |
| 4 | non-asd | 7 |
| 5 | nonfacial | 7 |
| 6 | 2685 | 5 |
| 7 | er-related | 5 |
| 8 | pe+hp+cvvhdf | 5 |
| 9 | co-evolving | 4 |
| 10 | high-sar | 4 |
| 11 | nonapproved | 4 |
| 12 | oab-related | 4 |
| 13 | dialysis-specific | 3 |
| 14 | double-controller | 3 |
| 15 | eukaryal | 3 |
| 16 | fear-arousing | 3 |
| 17 | non-thymidine | 3 |
| 18 | nondisease | 3 |
| 19 | placebo-nonremitter | 3 |
| 20 | right-dominant | 3 |
| 21 | srp-treated | 3 |
| 22 | viral-based | 3 |
| 23 | aspirin-like | 2 |
| 24 | dissection-related | 2 |
| 25 | erp-based | 2 |
| 26 | high-temperature-responsive | 2 |
| 27 | hypothermia-associated | 2 |
| 28 | ifn-γ-pretreated | 2 |
| 29 | needle-cleaning | 2 |
| 30 | non-mtx | 2 |
| 31 | non-oestrogen | 2 |
| 32 | non-pbde | 2 |
| 33 | non-β-diketone | 2 |
| 34 | noncalcium-containing | 2 |
| 35 | noncultivable | 2 |
| 36 | sc-mimicking | 2 |
| 37 | ultramicroscopic | 2 |
| 38 | well-rehearsed | 2 |
| 39 | 1-g/dl-higher | 1 |
| 40 | 1-pound | 1 |
| 41 | 1-propanol-containing | 1 |
| 42 | 117,579 | 1 |
| 43 | after-injection | 1 |
| 44 | alcoholic-based | 1 |
| 45 | caregiver/household | 1 |
| 46 | complianceto | 1 |
| 47 | contralateral/unaffected | 1 |
| 48 | contrast-unrelated | 1 |
| 49 | diet-modifying | 1 |
| 50 | drug-effective | 1 |
| 51 | environment-origin | 1 |
| 52 | feet-one | 1 |
| 53 | graphi | 1 |
| 54 | maintained/increased | 1 |
| 55 | mammosphere-forming | 1 |
| 56 | means-including | 1 |
| 57 | microheterogenous | 1 |
| 58 | non-constraint | 1 |
| 59 | non-crt-preventable | 1 |
| 60 | nonmegaloblastic | 1 |
| 61 | p53-activating | 1 |
| 62 | pospiviroids | 1 |
| 63 | post-strategy | 1 |
| 64 | scn-derived | 1 |
| 65 | self-neglect-were | 1 |
| 66 | serological/molecular | 1 |
| 67 | sex.the | 1 |
| 68 | si-adjudicated | 1 |
| 69 | tn1-3 | 1 |
| 70 | triaminoguanidine | 1 |
| 71 | un-affected | 1 |
| 72 | urinary-related | 1 |
| 73 | yet-undisclosed | 1 |
| 1 | 1-g/dl-higher | 1 |
| 2 | 1-pound | 1 |
| 3 | 1-propanol-containing | 1 |
| 4 | 117,579 | 1 |
| 5 | 2685 | 5 |
| 6 | after-injection | 1 |
| 7 | alcoholic-based | 1 |
| 8 | aspirin-like | 2 |
| 9 | caregiver/household | 1 |
| 10 | co-evolving | 4 |
| 11 | complianceto | 1 |
| 12 | contralateral/unaffected | 1 |
| 13 | contrast-unrelated | 1 |
| 14 | dialysis-specific | 3 |
| 15 | diet-modifying | 1 |
| 16 | dissection-related | 2 |
| 17 | double-controller | 3 |
| 18 | drug-effective | 1 |
| 19 | environment-origin | 1 |
| 20 | er-related | 5 |
| 21 | erp-based | 2 |
| 22 | eukaryal | 3 |
| 23 | fear-arousing | 3 |
| 24 | feet-one | 1 |
| 25 | graphi | 1 |
| 26 | high-sar | 4 |
| 27 | high-temperature-responsive | 2 |
| 28 | hypothermia-associated | 2 |
| 29 | ifn-γ-pretreated | 2 |
| 30 | maintained/increased | 1 |
| 31 | mammosphere-forming | 1 |
| 32 | means-including | 1 |
| 33 | microheterogenous | 1 |
| 34 | miscellaneous | 182 |
| 35 | needle-cleaning | 2 |
| 36 | non-asd | 7 |
| 37 | non-constraint | 1 |
| 38 | non-crt-preventable | 1 |
| 39 | non-mtx | 2 |
| 40 | non-oestrogen | 2 |
| 41 | non-pain | 12 |
| 42 | non-pbde | 2 |
| 43 | non-thymidine | 3 |
| 44 | non-β-diketone | 2 |
| 45 | nonapproved | 4 |
| 46 | noncalcium-containing | 2 |
| 47 | noncultivable | 2 |
| 48 | nondisease | 3 |
| 49 | nonfacial | 7 |
| 50 | nonmegaloblastic | 1 |
| 51 | oab-related | 4 |
| 52 | other | 90,133 |
| 53 | p53-activating | 1 |
| 54 | pe+hp+cvvhdf | 5 |
| 55 | placebo-nonremitter | 3 |
| 56 | pospiviroids | 1 |
| 57 | post-strategy | 1 |
| 58 | right-dominant | 3 |
| 59 | sc-mimicking | 2 |
| 60 | scn-derived | 1 |
| 61 | self-neglect-were | 1 |
| 62 | serological/molecular | 1 |
| 63 | sex.the | 1 |
| 64 | si-adjudicated | 1 |
| 65 | srp-treated | 3 |
| 66 | tn1-3 | 1 |
| 67 | triaminoguanidine | 1 |
| 68 | ultramicroscopic | 2 |
| 69 | un-affected | 1 |
| 70 | urinary-related | 1 |
| 71 | viral-based | 3 |
| 72 | well-rehearsed | 2 |
| 73 | yet-undisclosed | 1 |
| 1 | tn1-3 | 1 |
| 2 | 2685 | 5 |
| 3 | 117,579 | 1 |
| 4 | dialysis-specific | 3 |
| 5 | ultramicroscopic | 2 |
| 6 | nonmegaloblastic | 1 |
| 7 | alcoholic-based | 1 |
| 8 | viral-based | 3 |
| 9 | erp-based | 2 |
| 10 | maintained/increased | 1 |
| 11 | yet-undisclosed | 1 |
| 12 | well-rehearsed | 2 |
| 13 | si-adjudicated | 1 |
| 14 | srp-treated | 3 |
| 15 | ifn-γ-pretreated | 2 |
| 16 | hypothermia-associated | 2 |
| 17 | oab-related | 4 |
| 18 | dissection-related | 2 |
| 19 | er-related | 5 |
| 20 | urinary-related | 1 |
| 21 | contrast-unrelated | 1 |
| 22 | un-affected | 1 |
| 23 | contralateral/unaffected | 1 |
| 24 | scn-derived | 1 |
| 25 | nonapproved | 4 |
| 26 | caregiver/household | 1 |
| 27 | 1-pound | 1 |
| 28 | non-asd | 7 |
| 29 | non-pbde | 2 |
| 30 | sex.the | 1 |
| 31 | aspirin-like | 2 |
| 32 | non-crt-preventable | 1 |
| 33 | noncultivable | 2 |
| 34 | non-thymidine | 3 |
| 35 | triaminoguanidine | 1 |
| 36 | feet-one | 1 |
| 37 | non-β-diketone | 2 |
| 38 | self-neglect-were | 1 |
| 39 | nondisease | 3 |
| 40 | high-temperature-responsive | 2 |
| 41 | drug-effective | 1 |
| 42 | pe+hp+cvvhdf | 5 |
| 43 | means-including | 1 |
| 44 | sc-mimicking | 2 |
| 45 | mammosphere-forming | 1 |
| 46 | needle-cleaning | 2 |
| 47 | 1-propanol-containing | 1 |
| 48 | noncalcium-containing | 2 |
| 49 | fear-arousing | 3 |
| 50 | p53-activating | 1 |
| 51 | co-evolving | 4 |
| 52 | diet-modifying | 1 |
| 53 | graphi | 1 |
| 54 | nonfacial | 7 |
| 55 | eukaryal | 3 |
| 56 | non-oestrogen | 2 |
| 57 | non-pain | 12 |
| 58 | environment-origin | 1 |
| 59 | after-injection | 1 |
| 60 | complianceto | 1 |
| 61 | serological/molecular | 1 |
| 62 | high-sar | 4 |
| 63 | 1-g/dl-higher | 1 |
| 64 | other | 90,133 |
| 65 | double-controller | 3 |
| 66 | placebo-nonremitter | 3 |
| 67 | pospiviroids | 1 |
| 68 | miscellaneous | 182 |
| 69 | microheterogenous | 1 |
| 70 | right-dominant | 3 |
| 71 | non-constraint | 1 |
| 72 | non-mtx | 2 |
| 73 | post-strategy | 1 |